CuroGens Europa IVS: Financial statements 2019
CVR: 37602736
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CuroGens Europa IVS (CVR 37602736) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 2,609,943 and a net result of DKK -57,502 compared with DKK 536 the year before. That is an increase of 22.8% compared with the year before. The profit margin was -2.2%. Equity in the 2019 report amounted to DKK 30,199. The solvency ratio was 50.6%.
- Revenue
- DKK 2,609,943
- Gross Profit
- DKK 96,766
- Profit/Loss
- DKK -57,502
- Equity
- DKK 30,199
- Total Assets
- DKK 59,636
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 2.6M | 97K | -58K | 30K | - |
| 2018 | 2.1M | 5K | 536 | 636 | - |
| 2017 | 2.6M | 257K | 206K | 206K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CuroGens Europa IVS has published its annual report for 2018. Revenue came to DKK 2,125,013, and the net result was DKK 536.
About CuroGens Europa IVS
CuroGens Europa IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 20 December 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company has 1 employee (2020). In 2020, the company reported revenue of DKK 1,824,494 and a net result of DKK 15,632 compared with DKK -57,502 the year before. Equity in the 2020 report amounted to DKK 44,407.
